Valuation check: ELAT's PEG ratio is -13.3, below the Healthcare sector average of 1.26.
Get informed when a big investor buys or sells
+ Follow-13.30
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) (ELAT) currently reports a PEG ratio of -13.3. That is below the Healthcare sector average of 1.26. Use the charts on this page to explore Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s PEG ratio history and peer comparisons.
Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s PEG ratio of -13.3 is lower than the Healthcare sector average of 1.26. That is roughly 1158.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note)'s market price to a fundamental measure such as earnings, sales, or book value. At -13.3, ELAT can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of -13.3, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 1.26. From there, open related valuation or income-statement pages for Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note), and consider following ELAT for alerts when major investors trade the stock.
Elanco Animal Health- Units ( Purchase Contract & Senior Amortizing Note) is classified in the Healthcare sector. On PEG ratio, it currently shows -13.3 versus a sector average near 1.26. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ELAT with unrelated industries.